Download presentation
Presentation is loading. Please wait.
Published byたみじろう いまいだ Modified over 5 years ago
1
Selinexor and Low Dose Dexamethasone (Sd) in Patients with Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib and Anti-CD38 Ab Refractory Multiple Myeloma (MM): STORM Study by Dan T. Vogl, David Dingli, R. Frank Cornell, Carol Ann Huff, Sundar Jagannath, Divaya Bhutani, Rachid Baz, Ajay K Nooka, Joshua Richter, Craig E. Cole, Ravi Vij, Andrzej Jakubowiak, Rafat Abonour, Gary J. Schiller, Terri L. Parker, Luciano J. Costa, David Kaminetzky, James Hoffman, Andrew J. Yee, Ajai Chari, David S. Siegel, Rafael Fonseca, Scott VanWier, Gregory Ahmann, Ilsel Lopez, Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla Picklesimer, Sharon Friedlander, Cassandra Choe-Juliak, and A. Keith Stewart Blood Volume 128(22): December 2, 2016 ©2016 by American Society of Hematology
2
Activity of Sd in Patients with High Risk MM Cytogenetics.
Dan T. Vogl et al. Blood 2016;128:491 ©2016 by American Society of Hematology
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.